top of page

A quieter mind starts with a different kind of medicine

You weren't built to live like this

Anxiety is the most common mental health condition in the United States, and one of the most undertreated. Not because people aren't seeking help, but because the help available often doesn't go far enough. If you have lived with anxiety that medication hasn't quieted and therapy hasn't resolved, you know the particular exhaustion of managing a condition that never fully lets go. Ketamine-assisted therapy is offering a new pathway for patients whose anxiety has resisted conventional treatment.

What living with anxiety actually feels like

Anxiety isn't just worry. It is a body that won't stand down: the racing heart, the tightened chest, the mind that rehearses every possible outcome of every possible situation. It is canceling plans because the anticipation is too much. Lying awake at 3am with thoughts that won't resolve. Functioning, on the outside, while something inside is always braced for impact. You have probably been told to breathe through it, think differently about it, or simply manage it better. If that advice has not been enough, you are not alone and you are not failing.

Anxiety disorders (including generalized anxiety disorder, social anxiety disorder, and panic disorder) affect an estimated 40 million adults in the United States. First-line treatments including SSRIs, SNRIs, and cognitive behavioral therapy help a meaningful proportion of patients, but treatment-resistant anxiety is common and clinically significant. For patients who have cycled through multiple medications and years of therapy without achieving the relief they need, the question is not whether they have tried hard enough. It is whether the right tools have been available to them.

Turning down the alarm bells  

Anxiety disorders are rooted in a dysregulated threat-detection system. The brain can learn to read danger in situations that don't warrant it, and it can't easily be talked down despite the rational mind seeing the situation clearly. This is why the insight that therapy provides doesn't always translate into relief: the anxiety isn't primarily a thinking problem. It is a neurological one.

Ketamine addresses anxiety through mechanisms that bypass the limitations of conventional pharmacological approaches. As an NMDA receptor antagonist acting on the glutamate system, ketamine modulates the neural circuits underlying fear and threat response in ways that serotonin-targeting medications do not. Research suggests ketamine reduces activity in the brain regions associated with hypervigilance and fear conditioning, the same regions that anxiety disorders keep in a state of chronic overactivation.

Equally important is ketamine's effect on neuroplasticity. The heightened capacity for new neural connections that ketamine promotes creates a period during which the brain is more capable of forming new, calmer patterns of response to previously anxiety-provoking stimuli. With skilled therapeutic support surrounding the ketamine experience (in preparation, during the session, and in integration afterward) that window becomes an opportunity to establish a genuinely different relationship with anxiety rather than simply managing it better.

40M

 

adults in the US affected by anxiety disorders, the most common mental health condition

30-40%

 

of anxiety patients do not achieve adequate relief from first-line treatments

60-70%

 

response rate in patients who did not respond to traditional treatments like SSRIs 

Anxiety isn't one-size-fits-all

Anxiety is not one condition, it is a family of related disorders that share a common thread of dysregulated fear response but manifest differently from person to person. At Transcend Medicine, we work with patients across the full spectrum of anxiety presentations.

Generalized anxiety disorder is the persistent, wide-ranging worry that attaches itself to work, relationships, health, and the future simultaneously. This is one of the most common presentations, and a good candidate for ketamine therapy. Social anxiety disorder goes well beyond shyness, bringing a fear of social situations that can significantly limit a person's life and career. This form of anxiety does respond meaningfully to ketamine in emerging research. Panic disorder is the sudden, overwhelming physical episodes that can make ordinary situations feel dangerous, and is also responsive to ketamine's effects on fear circuitry.

If your anxiety doesn't fit neatly into a diagnostic category, or if it presents alongside depression or PTSD, we still want to hear from you. Comorbid presentations are the rule rather than the exception in mental health, and our clinical model is designed to treat the whole person rather than a single diagnosis.

The medicine creates space.
Therapy helps you inhabit it.

For anxiety specifically, the therapeutic context surrounding ketamine treatment is not just supportive, it is clinically essential. Ketamine creates a neuroplasticity window during which the brain is more capable of change, but that change doesn't happen automatically. It requires intentional therapeutic work to help you move into the new psychological space the medicine opens.

At Transcend Medicine, every patient has access to a licensed therapist from the first preparation session through the final integration appointment. Preparation work focuses on understanding your specific anxiety patterns, identifying what you most want to shift, and building the therapeutic safety that allows the ketamine experience to be exploratory rather than destabilizing. Integration work that follows treatment is where new insights are examined and new behavioral and cognitive patterns are deliberately cultivated.

This is not ketamine as a standalone intervention. It is ketamine as part of a complete therapeutic model designed to produce not just temporary relief, but the kind of lasting change that makes relief feel like a new baseline rather than a good week.

If anxiety has been running your life and conventional treatment hasn't been enough, something different is available.

DISCLAIMER: Statistics cited reflect ranges reported across peer-reviewed clinical literature and may vary based on patient population and study design. Individual results vary. Ketamine is administered off-label for psychiatric indications at Transcend Medicine. All treatment is preceded by a thorough medical evaluation by a licensed provider. This page does not constitute medical advice.

bottom of page